XML 108 R58.htm IDEA: XBRL DOCUMENT v3.24.1
Share capital and warrants (Tables)
12 Months Ended
Dec. 31, 2023
Share capital and warrants  
Summary of movements for the warrants outstanding

2023

2022

Weighted 

Weighted 

Number of 

average

Number of 

average 

    

Warrants

    

 exercise price

    

Warrants

    

exercise price

 

$

 

$

Balance – Beginning of year

    

24,046,640

    

17.86

4,929,791

    

30.00

Issued – Brokered private placement

 

7,752,916

22.80

Issued – Non-brokered private placement(i)

 

11,363,933

13.53

Issued – Bought deal financing(ii)

7,841,850

8.55

Warrants expired

(4,929,791)

30.00

Balance – End of year

 

26,958,699

12.93

24,046,640

17.86

Schedule of outstanding warrants with maturity dates and exercise terms

The outstanding warrants have the following a maturity dates and exercise terms:

Tranche

Warrant CUSIP

Maturity

Number of Warrants

Exercise Price(ii)

Conversion

2022 Brokered private placement

68828E221

02-Mar-27

7,752,916

$

14.75

Each one warrant entitling the holder thereof to purchase one common share of the Company

2022 Non-brokered private placement

68828E239

27-May-27

11,363,933

 US$

10.70

Each one warrant entitling the holder thereof to purchase one common share of the Company

2023 Bought deal financing

68828E262

02-Mar-26

7,841,850

$

8.55

Each one warrant entitling the holder thereof to purchase one common share of the Company

(i)Exercise price of warrants issued in non-brokered private placement is in USD.
(ii)On March 17, 2023, the Company received the required approvals to reduce the exercise price of the common share purchase warrants issued in 2022 under the brokered and non-brokered private placements. The exercise price to purchase one additional common share was reduced from $22.80 to $14.75 for the brokered private placement and from US$18.00 to US$10.70 for the non-brokered private placements. The increase in fair value of the amended share purchase warrants classified as equity instruments was estimated to $4.5 million and recorded directly in the Deficit, considering the fair value of the original warrants left at the date of the modification, using the Black-Scholes option pricing model based on the following assumptions:
Summary of assumptions used to determine warrants exercisable

Dividend per share

Expected volatility

66%

Risk-free interest rate

2.9%

Expected life

4 years

Share price

$6.20

Schedule of Capital Management

    

2023

    

2022

    

($)

    

($)

Long-term debt(i)

16,923

16,919

Total equity

585,188

730,434

Balance – End of year

602,111

747,353

(i)Excluding the additional available credit facility entered in by the Company on March 1, 2024 (Note 34).